SCHEMBL32678176

SCHEMBL32678176

COC1CCC(C(=O)Nc2nc3ccc(C(=O)N4CC5CC(C5)C4)cc3s2)C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.60
▸ RAB9A P51151 4/20 0.60
▸ HSP90AA1 P07900 1/20 0.60
▸ LMNA P02545 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.55
▸ GPR183 P32249 1/20 0.51
▸ LCK P06239 3/20 0.50
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ SENP8 Q96LD8 1/20 0.48
▸ SENP7 Q9BQF6 1/20 0.48
▸ SENP6 Q9GZR1 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ PIK3CA P42336 1/20 0.46
▸ PIK3CB P42338 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32678177 1.00 NPC1 (0.60) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678092 0.91 LMNA (0.72) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678093 0.91 LMNA (0.72) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678125 0.90 MAPK1 (0.74) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678127 0.90 MAPK1 (0.74) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678148 0.89 LMNA (0.61) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678153 0.89 LMNA (0.61) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678139 0.88 LMNA (0.60) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678137 0.88 LMNA (0.60) NPC1RAB9AHSP90AA1LMNAMAPK1
SCHEMBL32678122 0.86 NPC1 (0.67) NPC1RAB9AHSP90AA1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026043617-A1 COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF HEALTH CONDITIONS AND DRUG SCREENING REGLAGENE, INC. (US) 2026-02-26 — — WO disclosed
Send feedback